What is the diagnostic approach for primary hyperaldosteronism in a pregnant woman with hypertension resistant to standard antihypertensives and persistent hypokalemia?

Diagnosing Primary Aldosteronism in Pregnancy

Definitive diagnosis of primary aldosteronism cannot be made during pregnancy and must be deferred until after delivery, but you can establish a presumptive diagnosis based on suppressed plasma renin activity (PRA <4 ng/mL/h), persistent hypokalemia, and resistant hypertension. 1

Why Standard Diagnostic Criteria Don't Apply

Pregnancy creates a physiologic state of hyperreninemic hyperaldosteronism that fundamentally invalidates the aldosterone-to-renin ratio (ARR):

• PRA increases 4-7 fold during pregnancy due to additional renin sources from the uterus, ovaries, and placenta, plus estrogen-stimulated renin secretion 1
• Aldosterone levels rise 10-fold above baseline, driven by elevated renin and progesterone's competitive antagonism at mineralocorticoid receptors 1
• The ARR becomes unreliable as a screening tool in this hyperreninemic state 1

Diagnostic Approach During Pregnancy

Clinical Clues That Should Raise Suspicion

Look for this specific triad:

• Resistant hypertension (uncontrolled on standard pregnancy-safe antihypertensives)
• Persistent hypokalemia (though it may be masked by progesterone's mineralocorticoid receptor antagonism) 1
• Hypertension onset before 20 weeks gestation in a young woman 1

Biochemical Testing You Can Perform

Measure PRA and aldosterone levels with this interpretation:

• PRA <4 ng/mL/h is highly suggestive of PA in the context of pregnancy's expected hyperreninemic state 1
• A high ARR with suppressed PRA plus consistent clinical features strengthens the presumptive diagnosis 1
• Hypokalemia increases the probability, but normal potassium doesn't exclude PA due to progesterone effects 1

Critical Limitation: No Confirmatory Testing

Do not perform saline infusion tests or captopril suppression tests during pregnancy due to:

• Volume expansion risks with saline loading 1
• Potential toxic effects of captopril on the fetus 1

Imaging Options

Use MRI or ultrasound (both safe in pregnancy) to identify unilateral adrenal adenomas 1. The presence of a unilateral adenoma in a young pregnant woman with hypertension before 20 weeks plus biochemical evidence (suppressed PRA) may provide sufficient presumptive confirmation to consider second-trimester adrenalectomy if hypertension is refractory 1.

Post-Delivery Confirmation

Perform definitive confirmatory testing after delivery when the renin-angiotensin-aldosterone system normalizes and standard diagnostic protocols (saline suppression test, captopril test) can be safely applied 1.

Common Pitfalls to Avoid

1. Don't dismiss the diagnosis because aldosterone is elevated—it should be elevated in pregnancy, but renin should be even more elevated. The key is suppressed renin 1

2. Don't rely on hypokalemia alone—progesterone's mineralocorticoid receptor antagonism can normalize potassium despite aldosterone excess 1

3. Don't attempt standard confirmatory testing—the risks outweigh benefits, and results would be uninterpretable anyway 1

4. Don't delay treatment while pursuing diagnostic certainty—maternal and fetal complications from uncontrolled hypertension are the priority concern 1, 2

Why This Matters for Outcomes

Undiagnosed PA in pregnancy carries significant risks including maternal stroke, preeclampsia, intrauterine growth restriction, preterm delivery, and stillbirth 2, 3, 4. Early recognition, even if presumptive, allows for appropriate pregnancy-safe management and planning for definitive diagnosis and treatment postpartum.